The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Patents for Victoza and Saxenda have now expired. So other drug companies are working to develop "generic" versions.

I nterest in the weight loss drug Saxenda has skyrocketed. According to Google Trends, searches have increased by a staggering 141 per cent over the past 12 months with many clamouring to get hold ...

Trish Webster died of acute gastrointestinal illness after several months of taking Ozempic and Saxenda Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

It’s also available as the brand-name injection Saxenda, which is approved for weight loss. Victoza has a boxed warning. A boxed warning is the most serious warning from the Food and Drug ...

The study used the company's older GLP-1 agonist therapy Saxenda (liraglutide), which requires a daily injection, rather than its top-selling once-weekly obesity drug Wegovy (semaglutide), and ...

Saxenda continues to develop a dominant position in obesity pharmacotherapy however, and Novo Nordisk said the drug currently has a market share of 63% worldwide.

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British ...